Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Smith

Showing results (191-200 of 542) with videos related to

Pageof 55
Sort By:
JAMA Pediatrics|November 20, 2018
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationKanecia O Zimmerman, P Brian Smith, Ann W McMahon, et al.
Journal of Clinical Pharmacology|December 14, 2011
Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy resultsJohn P Gibbs, Jill Fredrickson, Todd Barbee, et al.
Cancer Chemotherapy and Pharmacology|April 25, 2012
The "survivin suppressants" NSC 80467 and YM155 induce a DNA damage responseTrevor G Glaros, Luke H Stockwin, Michael E Mullendore, et al.
The American Journal of Tropical Medicine and Hygiene|October 9, 2008
Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetesBlanca I Restrepo, Susan P Fisher-Hoch, Brian Smith, et al.
Clinical Chemistry|August 28, 2014
The changing face of laboratory medicine: a more service and less academically oriented profession?Mitchell G Scott, Nader Rifai, Brian Smith, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 29, 2015
Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjectsRameshraja Palaparthy, Christopher Banfield, Paco Alvarez, et al.
American Journal of Perinatology|September 3, 2016
Dolichocephaly in Preterm Infants: Prevalence, Risk Factors, and Early Motor OutcomesDana B McCarty, Jennifer R Peat, William F Malcolm, et al.
Clinical Pharmacokinetics|October 7, 2010
Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumabBing-Bing Yang, Peggy Lum, Alin Chen, et al.
Respiratory Care|March 16, 2012
Isoflurane for life-threatening bronchospasm: a 15-year single-center experienceDavid A Turner, David Heitz, Mehrengise K Cooper, et al.
The Journal of Pediatrics|July 24, 2010
Prevalence of iron deficiency in children with Down syndromeNatalia E Dixon, Blythe G Crissman, P Brian Smith, et al.
Pageof 55

Showing results (191-200 of 542) with videos related to

Sort By:
Pageof 55
JAMA Pediatrics|November 20, 2018
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationKanecia O Zimmerman, P Brian Smith, Ann W McMahon, et al.
Journal of Clinical Pharmacology|December 14, 2011
Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy resultsJohn P Gibbs, Jill Fredrickson, Todd Barbee, et al.
Cancer Chemotherapy and Pharmacology|April 25, 2012
The "survivin suppressants" NSC 80467 and YM155 induce a DNA damage responseTrevor G Glaros, Luke H Stockwin, Michael E Mullendore, et al.
The American Journal of Tropical Medicine and Hygiene|October 9, 2008
Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetesBlanca I Restrepo, Susan P Fisher-Hoch, Brian Smith, et al.
Clinical Chemistry|August 28, 2014
The changing face of laboratory medicine: a more service and less academically oriented profession?Mitchell G Scott, Nader Rifai, Brian Smith, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 29, 2015
Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjectsRameshraja Palaparthy, Christopher Banfield, Paco Alvarez, et al.
American Journal of Perinatology|September 3, 2016
Dolichocephaly in Preterm Infants: Prevalence, Risk Factors, and Early Motor OutcomesDana B McCarty, Jennifer R Peat, William F Malcolm, et al.
Clinical Pharmacokinetics|October 7, 2010
Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumabBing-Bing Yang, Peggy Lum, Alin Chen, et al.
Respiratory Care|March 16, 2012
Isoflurane for life-threatening bronchospasm: a 15-year single-center experienceDavid A Turner, David Heitz, Mehrengise K Cooper, et al.
The Journal of Pediatrics|July 24, 2010
Prevalence of iron deficiency in children with Down syndromeNatalia E Dixon, Blythe G Crissman, P Brian Smith, et al.
Pageof 55